In the last few decades, the function of tumor-infiltrating lymphocytes (TILs), especially the cytotoxic CD8+ T cells and other subgroups of T cells, such as CD4+ T cells and Tregs on tumor progression and patient prognosis have been deeply explored (7–9). This evidence concerns the gene CD8A and neoplasm.